Clinical Trials

Alefacept in psoriatic arthritis

Addition of subcutaneous alefacept to treat psoriasis in patients partially responsive to anti-TNFalpha agents - clinical experiences

 
to Continue Reading, Login Now
 

Please Login

 
 
  
 
 
If you are a registered user but you have forgotten your password, please click here
 
If you are not a registered user, please register here